Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,2-dihydro-8-(4-methylpiperazin-1-yl)-4-phenylimidazol[3,2-e]pyrazine 5-oxide + NADH
1,2-dihydro-8-(4-methylpiperazin-1-yl)-4-phenylimidazol[3,2-e]pyrazine + NAD+
-
Substrates: potential bioreductive drug, trivial name RB90740
Products: -
?
1,2-naphthoquinone + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
1,4-naphthoquinone + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
2 ferricyanide + NADH + H+
2 ferrocyanide + NAD+
Substrates: -
Products: -
?
2 ferricyanide + NADPH
2 ferrocyanide + NADP+ + H+
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
2 ferricytochrome b5 + NADPH
2 ferrocytochrome b5 + NADP+ + H+
Substrates: with NADPH the enzyme shows about 20% of the activity with NADH
Products: -
?
2 ferricytochrome b5 + NADPH + H+
2 ferrocytochrome b5 + NADP+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
2 ferricytochrome c + NADH + H+
2 ferrocytochrome c + NAD+
2-hydroxyestradiol + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
2-methyl-1,4-naphthoquinone + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
2-[4-iodophenyl]-3-[4-nitrophenyl]-5-[2,4-disulfophenyl]-2H tetrazolium monosodium salt + NADH
?
Substrates: -
Products: -
?
5alpha-dihydrotestosterone + acceptor
?
-
Substrates: -
Products: -
r
9,10-phenanthrenequinone + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
aquacobalamin + NADH
reduced aquacobalamin + NAD+
-
Substrates: in the presence of outer membrane cytochrome b, no activity with cyanocobalamin
Products: -
?
benzamidoxime + NADH
?
-
Substrates: in the presence of cytochrome b5
Products: -
?
Cu2+-citrate + NADH
Cu+-citrate + NAD+
dapsone hydroxylamine + NADH
?
-
Substrates: in the presence of cytochrome b5
Products: -
?
deoxyhemerythrin + O2
?
-
Substrates: -
Products: -
?
Fe3+-ammonium sulfate + NADH
Fe2+-ammonium sulfate + NAD+
-
Substrates: strongly elevated by the addition of cytochrome b5
Products: -
?
Fe3+-ATP + NADH
Fe2+-ATP + NAD+
Fe3+-citrate + NADH
Fe2+-citrate + NAD+
Fe3+-EDTA + NADH
Fe2+-EDTA + NAD+
Fe3+-histidine + NADH
Fe2+-histidine + NAD+
-
Substrates: strongly elevated by the addition of cytochrome b5
Products: -
?
Fe3+-nitrilotriacetate + NADH
Fe2+-nitrilotriacetate + NAD+
-
Substrates: in the presence of cytochrome b5, iron chelate reduction in descending order: Fe3+-nitrolotriacetate, Fe3+-ADP, Fe3+-diphosphate, Fe3+-citrate
Products: -
?
ferricytochrome b5 + 4-(5-(4-[amino(hydroxyamino)methyl]phenyl)-2-furyl)-N'-hydroxybenzenecarboximidamide
ferrocytochrome b5 + ?
-
Substrates: metabolite of DB289, an antimicrobial prodrug of furamidine
Products: -
?
ferricytochrome b5 + 4-(5-(4-[amino(hydroxyamino)methyl]phenyl)-2-furyl)-N'-methoxybenzenecarboximidamide
ferrocytochrome b5 + ?
-
Substrates: metabolite of DB289, an antimicrobial prodrug of furamidine
Products: -
?
ferricytochrome b5 + cytoglobin 1
ferrocytochrome b5 + ?
Substrates: -
Products: -
?
ferricytochrome b5 + cytoglobin 2
ferrocytochrome b5 + ?
Substrates: -
Products: -
?
ferricytochrome b5 + globin x
ferrocytochrome b5 + ?
Substrates: -
Products: -
?
ferricytochrome b5 + N-hydroxy-2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine
ferrocytochrome b5 + ?
-
Substrates: arylhydroxylamine carcinogen found in grilled meat
Products: -
?
ferricytochrome b5 + N-hydroxy-4-aminobiphenyl
ferrocytochrome b5 + ?
-
Substrates: arylhydroxylamine carcinogen found in cigarette smoke
Products: -
?
lucigenin + NADH
?
Substrates: -
Products: -
?
methemerythrin + NADH
deoxymethemerythrin + NAD+
-
Substrates: -
Products: -
?
methemoglobin + NADH
hemoglobin + NAD+
-
Substrates: provides functional hemoglobin
Products: -
?
methemoglobin-ferrocyanide complex + NADH
reduced methemoglobin-ferrocyanide complex + NAD+
-
Substrates: -
Products: -
?
NADH + ferricyanide
NAD+ + H+ + ferrocyanide
NADH + ferricytochrome b5
NAD+ + H+ + 2 ferrocytochrome b5
NADH + ferricytochrome b5
NAD+ + H+ + ferrocytochrome b5
NADH + ferricytochrome b5 + oxidized soluble guanylate cyclase
NAD+ + H+ + ferrocytochrome b5 + reduced soluble guanylate cyclase
-
Substrates: -
Products: -
?
NADH + ferricytochrome c
NAD+ + H+ + ferrocytochrome c
NADH + methemoglobin
NAD+ + hemoglobin
-
Substrates: -
Products: -
?
NADH + oxidized 2,6-dichlorophenolindophenol
NAD+ + H+ + reduced 2,6-dichlorophenolindophenol
NADH + oxidized cytochrome c
NAD+ + H+ + reduced cytochrome c
-
Substrates: -
Products: -
?
NADH + oxidized nitroblue tetrazolium
NAD+ + H+ + reduced nitroblue tetrazolium
-
Substrates: -
Products: -
?
NADH + testosterone
?
-
Substrates: -
Products: -
r
NADPH + ferricyanide
NADP+ + H+ + ferrocyanide
NADPH + ferricytochrome b5
NADP+ + H+ + ferrocytochrome b5
nitrofurantoin + O2 + NADH + H+
?
-
Substrates: -
Products: -
?
sulfamethoxazole hydroxylamine + NADH
?
-
Substrates: in the presence of cytochrome b5
Products: -
?
additional information
?
-
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
Substrates: -
Products: -
?
2 ferricyanide + NADPH
2 ferrocyanide + NADP+ + H+
-
Substrates: -
Products: -
?
2 ferricyanide + NADPH
2 ferrocyanide + NADP+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: specific for NADH as electron donor, artificial acceptors: ferricyanide, 2,6-dichlorphenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: no acceptors: ubiquinone-30, menadione, dihydrofolate, lipoamide
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: poor donor: NADPH
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: artificial acceptor: ferricyanide, high reactivity with NADPH as electron donor
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: specific for NADH as electron donor, artificial acceptors: ferricyanide, 2,6-dichlorphenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: poor electron acceptors: methylene blue, ferricytochrome c, O2, oxidized glutathione, methemoglobin
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: artificial electron acceptor in the presence of menadione: cytochrome c
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: additional electron donors: deamino-NADH, 3-acetylpyridine-NADH
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: artificial acceptors: p-benzoquinone, 5-hydroxy-1,4-naphthoquinone, nitroblue-tetrazolium
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: additional acceptor: methemoglobin-ferrocyanide complex
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in metabolism of endogenous compounds such as steroids, drugs, carcinogens, environmental pollutants
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: enzyme participates in methemoglobin reduction in erythrocytes, in other tissues it plays a role in elongation and desaturation of fatty acids, P-450 mediated drug metabolism and cholesterol biosynthesis as part of the microsomal electron transfer system
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: soluble form of erythrocytes: reduction of methemoglobin
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, enzyme in presence of cytochrome b5 supports activity of CYP2E1
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, participates in the regeneration of vitamin E and of ascorbate, maintains antioxidant levels and is therefore involved in the protection of membrane lipids from peroxidation, considered as a constitutive housekeeping enzyme
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: recessive congenital methaemoglobinaemia, is caused by NADH-cytochrome b5 reductase deficiency. Two distinct clinical forms, types I and II, are recognized, both characterized by cyanosis from birth. In type II, the cyanosis is accompanied by neurological impairment and reduced life expectancy
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: the electrostatic interactions between the lysyl residues (K42, K126, K163, and K164) in the enzyme and the carboxyl groups (E47, E48, E52, E60, and D64) of cytochrome b5 keep the proteins tightly complexed and are suitable for electron transfer, reaction mechanism, overview
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: potassium ferricyanide, cytochrome b5, or NADH-2,6-dichlorophenol-indophenol can act as electron acceptors
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, removal of reactive oxygen species
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: uses both NADH and NADPH as electron donors, artificial acceptors: ferricyanide, 2,6-dichlophenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: low activity with trypsin-solubilized cytochrome b5
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: specific for NADH as electron donor, artificial acceptors: ferricyanide, 2,6-dichlorphenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: additional acceptor: hemin
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: poor donor: NADPH
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: additional acceptor: methemoglobin-ferrocyanide complex
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: artificial acceptor: ferricyanide
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: additional acceptor: methemerythrin
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: specific for NADH as electron donor, artificial acceptors: ferricyanide, 2,6-dichlorphenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: recombinant enzyme, very low activity with NADPH
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in desaturation of fatty acids
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, enzyme defects causes methemoglobinemia type I or type II
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, mutations can cause methemoglobinemia type I or II
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics, removal of reactive oxygen species
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: specific for NADH as electron donor, artificial acceptors: ferricyanide, 2,6-dichlorphenolindophenol
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: enzyme complex drives the entire sterol 14-demethylation reaction
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: involved in desaturation of fatty acids
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: -
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: involved in the synthesis of fatty acids and cholesterol, and in the oxidation of xenobiotics
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
-
Substrates: membrane bound form of somatic cells: essential for lipid metabolism
Products: -
?
2 ferricytochrome b5 + NADH
2 ferrocytochrome b5 + NAD+ + H+
Substrates: enzyme is assumed to be part of an endoplasmic reticulum associated redox chain that oxidizes NADH to provide electrons via cytochrome b5 to endoplasmic reticulum associated fatty acyl desaturase and related hydroxylases as in mammals
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
Substrates: increases in the presence of cytochrome b5
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
Substrates: in the presence of outer membrane cytochrome b
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
Substrates: cytochrome b5/cytochrome b5 reductase FAD-domain-fusion protein, NADPH is preferred
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
Substrates: reduces also ferricyanide
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
Substrates: isoforms I and II, 16% and 27% of Fe3+-citrate reduction respectively
Products: -
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
Substrates: isoforms I and II, 16% and 27% of Fe3+-citrate reduction respectively
Products: -
?
2 ferricytochrome c + NADH + H+
2 ferrocytochrome c + NAD+
-
Substrates: -
Products: -
?
2 ferricytochrome c + NADH + H+
2 ferrocytochrome c + NAD+
-
Substrates: -
Products: -
?
Cu2+-citrate + NADH
Cu+-citrate + NAD+
Substrates: reduces also ferricyanide
Products: -
?
Cu2+-citrate + NADH
Cu+-citrate + NAD+
Substrates: isoforms I and II, 59 and 47% of Fe3+-citrate reduction respectively
Products: -
?
Cu2+-citrate + NADH
Cu+-citrate + NAD+
Substrates: isoforms I and II, 59 and 47% of Fe3+-citrate reduction respectively
Products: -
?
Fe3+-ATP + NADH
Fe2+-ATP + NAD+
-
Substrates: reconstituted system containing NADH, cytochrome b5 reductase, cytochrome b5 and microsomal lipids catalyzes lipid peroxidation in the presence of ferric-ATP, ferric-histidine and ferric-ammonium sulfate
Products: -
?
Fe3+-ATP + NADH
Fe2+-ATP + NAD+
-
Substrates: ferric-EDTA is not reduced
Products: -
?
Fe3+-citrate + NADH
Fe2+-citrate + NAD+
Substrates: isoforms I and II
Products: -
?
Fe3+-citrate + NADH
Fe2+-citrate + NAD+
Substrates: isoforms I and II
Products: -
?
Fe3+-citrate + NADH
Fe2+-citrate + NAD+
Substrates: reduces also ferricyanide
Products: -
?
Fe3+-EDTA + NADH
Fe2+-EDTA + NAD+
Substrates: isoforms I and II
Products: -
?
Fe3+-EDTA + NADH
Fe2+-EDTA + NAD+
Substrates: isoforms I and II
Products: -
?
Fe3+-EDTA + NADH
Fe2+-EDTA + NAD+
<